Vaccine Types:
Vaccine abbreviations in column A conform to the standarized nomenclature developed by the
Vaccine Identification Standards Initiative:
|
DTPa
|
|
|
Diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine
|
|
DTPa-HIB
|
|
|
Diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine, and Haemophilus influenzae type B conjugate vaccine
|
|
HIB
|
|
|
Haemophilus influenzae type B vaccine
|
|
HIB-HBV
|
|
|
Haemophilus influenzae type B conjugate, and Hepatitis B virus vaccine
|
|
HAV
|
|
|
Hepatitis A virus vaccine
|
|
HBV
|
|
|
Hepatitis B virus vaccine
|
|
INF
|
|
|
Influenza virus vaccine
|
|
MMR
|
|
|
Measles virus, Mumps virus, Rubella virus vaccine
|
|
PNUcn-7
|
|
|
Pneumococcal (Streptococcus pneumoniae) conjugate vaccine, 7-valent
|
|
POLIPV
|
|
|
Polio virus inactivated (injectable) vaccine
|
|
Td
|
|
|
Tetanus toxoid, and diphtheria toxoid (reduced antigen quantity for adults)
|
|
VAR
|
|
|
Varicella (chickenpox) (varicella zoster virus) vaccine
|
(Return
To Top)
Step 1E. Preparation Costs:The
preparation cost represents the estimated cost of labor time, per dose, to open
the vaccine packaging and prepare it for administration to the patient. These
estimates may vary from user to user, and may be adjusted accordingly. It is
varied here by packaging type. Default values are $0.25 for pre filled
syringes, $0.75 for liquid vaccines in vials, and $1.50 for
powdered/lyophilized vaccines. See references 1 and 3 in
Background page for further discussion on these costs.
Preparation costs for all vaccines of a given packaging type
can be set en bloc by using the text boxes and the Set All
button at the top of the "Preparation Cost - $/Dose" column G of the Available
Vaccines Table. One can also change the preparation cost of individual vaccines
by modifying the text-entry box in column G of the row containing the specific
product.
(Return
To Top)
Step 1F. Vaccine Wastage by Expiration:
Columns I and J of the Available Vaccines Table allow users
to consider the effect of vaccine wastage by expiration. Default expiration
lives are set to nominal values of 12 or 18 months that were
obtained for various vaccine products from CDC personnel in charge of Federal
vaccine purchase contracts. Default wastage rates of 1% and
0.75% have been assigned to these products, respectively, based on a 1%
minimum wastage rate reported by studies on vaccine wastage (see
Frequency and causes of vaccine wastage)
For each vaccine product, the user can enter a custom nominal wastage rate in
column I. If the expiration life in column J is equal to the given default, the
algorithm will use the nominal wastage rate provided in column I as the wastage
rate for the particular product. Otherwise, it will proportionally increase or
decrease the wastage rate from its nominal value according to whether the given
expiration life is lower or higher than the nominal value, respectively.
(Return
To Top)
Users can create and add new monovalent and combination
vaccines for inclusion in the Available Vaccines Table. For each new vaccine,
one-at-a-time, use the menu to select: (1) manufacturer, (2) purchase price per
dose, (3) packaging type, (4) preparation cost per dose, (5) antigen(s) in this
vaccine (multiple items permitted for a combination), and (6) ages when the
product is approved for use. Click the Add Vaccine button to
add the new vaccine for consideration. For additional vaccines, repeat this
step.
HAV antigen is not yet in the add-new-vaccines menu
because this prototype version of the software does not yet consider potential
variation in the doses and ages of its use. These might vary from the
algorithm's assumption of two doses at 24 and 30 months, according to ACIP recommendations and the current schedule.
(Return
To Top)
The "Visit Cost" is the amount attributed for each separate
visit to a vaccine provider. The default value is $40.00. The visit cost does
not currently affect the vaccines chosen by the algorithm. To do so would
require the use of some hypothetical vaccine which avoids the need for a
vaccination visit otherwise required by the schedule. Visit cost may be set to
$ 0.00 to exclude this cost from calculation by the algorithm of the overall
cost of immunization.
(Return
To Top)
The injection cost represents an estimate of the direct
medical costs to administer each vaccine and/or the indirect and societal costs
of deferred visits resulting from objection to multiple injections. The default
value is $15.00. Injection cost also may represent the value to parents in
avoiding extra injections for their children, and thus to reduce pain and
suffering, as determined by willingness-to-pay studies. The injection cost
amount affects the vaccines chosen by the algorithm by quantifying the extra
value of combination vaccines which reduce the overall number of required
injections. Injection cost may be set to $ 0.00 to exclude this cost from
consideration by the algorithm.
(Return
To Top)
The Advisory Committee on Immunization Practices (ACIP) states:
"Data are insufficient to document the safety,
immunogenicity, and efficacy of using DTaP vaccines from different
manufacturers in a mixed sequence. For this reason, the ACIP recommends that
whenever feasible, the same brand of DTaP vaccine should be used for all doses
of the vaccination series. However, the vaccine provider might not know or have
available the type of DTaP vaccine previously administered to a child. Neither
circumstance should present a barrier to administration of DTaP vaccine and any
of the available licensed DTaP vaccines can be used to complete the vaccination
series."
The algorithm defaults to the preference that the formulary
will contain pertussis vaccines (e.g., in DTPa, DTPa-HIB,
or other possible combinations) only from the same manufacturer. To remove this
requirement and permit mixing of pertussis vaccines for different doses in the
series, click to set the Do Not Match button.
(Return
To Top)
Scenario 1 requires the algorithm to schedule three doses of HBV,
starting at age 2 months, and is the default setting. Scenario 2 schedules a
perinatal outpatient visit (age "0-to-1 month") for the first HBV dose
from the formulary, and the algorithm calculates the vaccine, preparation,
visit, and injection costs for this dose. Scenario 3 assumes only two remaining
doses of vaccine are needed by patients to be immunized from the formulary, and
ignores all costs of the first HBV dose provided elsewhere.
(Return
To Top)
To save your customized settings in the Available Vaccines
Table and in Steps 3 through 6, so that they need not be
entered for future solution runs, enter a file name and click the Save
Configuration button. To take advantage of this feature, you
must have already logged in, or you can log in by entering your username and
password in this section. This step can be skipped, if desired.
Retrieving saved configurations: Once the user has
logged in, a list of saved configurations becomes available on the side bar at
the left margin of the page. Selecting one of these configurations and clicking
the Load button will restore the saved settings into the Available
Vaccines Table and Steps 3 through 6.
(Return
To Top)
To run the algorithm to solve for your formulary, click the Solve
button. For your convenience in printing out or saving an electronic record, a
complete summary of the Available Vaccines Table and all its
selected and customized settings will be provided along with your solution,
which will appear in a separate browser window.
The Solution window will include:
(1) a table that specifies the vaccines (by brand) that will
be administered at each age (visit), and the per-visit and total costs of
vaccines, injections, preparation, and visits;
(2) a list of all vaccines that were competed by the
algorithm -- whether selected or not -- including the user's settings for their
prices and preparation costs, and for the injection and visit costs, and other
algorithm choices; and
(3) a "shopping list" detailing the number of vaccines to
purchase, by vaccine type and manufacturer, for each hypothetical child to be
immunized by the formulary.
Four requirements must be met in order for a specific
vaccine to be considered by the algorithm:
(1) The To Be Considered check box in column
H of the corresponding row must be checked.
(2) One of the radio buttons in columns C, D, or E must be
selected in the row containing the specific vaccine, and a price must be shown
above the selected button. For Custom prices, the user must enter a positive
number in the text field above the Custom radio button in column E. This field
may not be editable unless the user first clicks the Custom radio button. For Added
Vaccines, the price entered by the user is treated as a Custom
price; therefore the Custom button is selected and locked for these vaccines.
(3) For Custom prices and for added vaccines, the entered
price must be in the range $0.00 to $299.00. This upper limit helps minimize
typographical errors. For example, it avoids a vaccine price entered
erroneously as $300.00, instead of the intended $30.00.
(4) A preparation cost in the range $0.00 to $19.00 must be
entered in column G.
(Return
To Top)
ERROR MESSAGE CAUSES: When the user initially loads
the page, the buttons on columns C, D and E are unselected for all rows. Before
the algorithm may be run, every row for which the check box in column H is
checked must satisfy requirements (2), (3), and (4) above.
At present, the algorithm defaults to include all available
vaccines which may satisfy the Recommended Childhood Immunization Schedule.
However, the user may exclude all vaccines capable of satisfying one of the
requirements in the schedule. This will result in a warning message on the
solution page. In such cases, the formulary will satisfy only the diseases
represented by the remaining antigens considered. For example, if all HIB, DTPa-HIB,
and HIB-HBV vaccines are excluded, the formulary will fail to satisfy
the requirement to prevent haemophilus influenzae type b disease. The
algorithmn will produce NO results ONLY when no vaccines are considered or when
the considered vaccines do not satisfy the requirements of the schedule for all
antigens present in the considered vaccines.
(Return
To Top)